Search Results - "Reddy, Kaunteya"
-
1
Chemotherapeutic Drugs Induce PPAR-γ Expression and Show Sequence-Specific Synergy with PPAR-γ Ligands in Inhibition of Non–Small Cell Lung Cancer
Published in Neoplasia (New York, N.Y.) (01-06-2008)“…Preclinical studies have shown that peroxisome proliferator–activated receptor γ (PPAR-γ) ligands can exert antitumor effects against non–small cell lung…”
Get full text
Journal Article -
2
The changing paradigm of treating pancreatic neuroendocrine tumors
Published in Journal of the National Comprehensive Cancer Network (01-12-2011)Get more information
Journal Article -
3
The Barriers to Colorectal Cancer Screening: Time for Colonoscopy Super Pac: 2088
Published in The American journal of gastroenterology (01-10-2013)Get full text
Journal Article -
4
Su1574 Characterization of the Woodchuck Model to Study Antiangiogenic Therapies Against Hepatocellular Cancer
Published in Gastroenterology (New York, N.Y. 1943) (01-05-2012)Get full text
Journal Article -
5
Abstract 4546: Variability analysis of dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) of hepatocellular carcinoma (HCC)
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…INTRODUCTION: HCC is a highly vascular, rapidly fatal cancer and antiangiogenic drugs have shown clinical benefit despite lack of radiographic tumor shrinkage…”
Get full text
Journal Article -
6
Validating the woodchuck model for studying antiangiogenic therapies for human hepatocellular carcinoma (HCC)
Published in Journal of clinical oncology (01-02-2012)“…Abstract only 239 Background: Anti-angiogenic agents have become the backbone of advanced HCC treatment and provide clinical benefit despite infrequent…”
Get full text
Journal Article -
7
Gender Preference in Screening Colonoscopy: 1527
Published in The American journal of gastroenterology (01-10-2009)Get full text
Journal Article -
8
Chemotherapeutic Drugs Induce PPAR-γ Expression and Show Sequence-Specific Synergy with PPAR-γ Ligands in Inhibition of Non-Small Cell Lung Cancer1
Published in Neoplasia (New York, N.Y.) (01-06-2008)“…Preclinical studies have shown that peroxisome proliferator-activated receptor γ (PPAR-γ) ligands can exert antitumor effects against non-small cell lung…”
Get full text
Journal Article